E2F3 and neoplasm: In contrast, sar@LIP induced the up-regulation of a broad spectrum of genes related to the positive induction of cell proliferation (CCND1, E2F3, PDGFRB and TEGT, a described BAX inhibitor), which corresponds to the tumor growth enhancement observed in vivo after sar@LIP administration.